DEFINITIVE PROXY STATEMENT

Company

Edesa Biotech, Inc.

Filed

January 25, 2016

Period of Report

March 17, 2016

Accession Number

0001144204-16-076862

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →